Invention Grant
- Patent Title: Cancer therapeutics
-
Application No.: US14385140Application Date: 2013-03-15
-
Publication No.: US09833508B2Publication Date: 2017-12-05
- Inventor: Sean Senn , Ilya Rachman
- Applicant: IMMIX CORPORATION
- Applicant Address: US CA Los Angeles
- Assignee: Immix Biopharma, Inc.
- Current Assignee: Immix Biopharma, Inc.
- Current Assignee Address: US CA Los Angeles
- Agency: Archer Norris, PLC
- Agent Sean D. Senn
- International Application: PCT/US2013/032153 WO 20130315
- International Announcement: WO2013/138735 WO 20130919
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K9/107 ; A61K31/12 ; A61K31/713 ; A61K45/06 ; A61K39/00 ; C07K16/28 ; C12N15/113 ; A61K47/69
Abstract:
The invention relates to the treatment of cancer. In one embodiment, the present invention provides a composition comprising a micelle construct attached to a glut-1 antibody and a curcumin molecule. In another embodiment, the present invention provides a method of treating colon and/or breast cancer by administering a therapeutically effective amount of composition comprising a targeted construct attached to an inhibitor of NF-kB.
Public/Granted literature
- US20150110877A1 CANCER THERAPEUTICS Public/Granted day:2015-04-23
Information query
